{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:30:05Z","timestamp":1785868205333,"version":"3.56.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["24-210"],"award-info":[{"award-number":["24-210"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Background<\/jats:title>\n All individuals with colorectal cancer (CRC) should undergo genetic cancer risk assessment given its implications for personalized treatment, surveillance, risk-reduction strategies, and cascade testing. Universal screening using immunohistochemistry (IHC) for mismatch repair (MMR) proteins in tumor tissue, when combined with clinical criteria, is essential for identifying individuals at higher risk for carrying germline pathogenic variants (PVs) in resource limited countries.<\/jats:p>\n <\/jats:sec>\n \n Patients and Methods<\/jats:title>\n The spectrum of PVs in cancer susceptibility genes was characterized using NGS multigene panel assays among selected patients with CRC at two centers in Mexico. Germline genetic testing was used as the reference standard to evaluate the diagnostic accuracy of the referral criteria.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n From September 2018 to October 2024, 208 patients were enrolled. The median age at diagnosis was 45.0 years; 52.4% were women, 48.6% had deficient-MMR CRC, and 38.0% reported family history of CRC. Germline PVs were identified in 32.2% (n\u2009=\u200967); of these, 77.6% (n\u2009=\u200952) had Lynch syndrome (30\n MLH1<\/jats:italic>\n , 14\n MSH2<\/jats:italic>\n , 6\n MSH6<\/jats:italic>\n , and 2\n PMS2<\/jats:italic>\n ), while 22.4% (n\u2009=\u200915) harbored PVs in other genes (4\n ATM<\/jats:italic>\n , 3\n BRCA1<\/jats:italic>\n , 3\n CHEK2<\/jats:italic>\n , 2\n TP53<\/jats:italic>\n , 1\n BRCA2<\/jats:italic>\n , 1\n BRIP1<\/jats:italic>\n , and 1\n PALB2<\/jats:italic>\n ). Additionally, one individual harbored a monoallelic PV in\n MUTYH<\/jats:italic>\n . The Amsterdam II criteria demonstrated the highest specificity (Sensitivity 56.0%, Specificity 91.9%), while the revised Bethesda criteria (Sensitivity 98.1%, Specificity 19.9%) and IHC for MMR proteins (Sensitivity 91.2%, Specificity 68.7%) exhibited high sensitivity. The area under the ROC curve for PREMM5 was 0.822 (95% CI 0.746\u20130.898).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n PREMM5, Revised Bethesda criteria and IHC for MMR proteins effectively prioritized patients eligible for germline genetic testing in resource-limited settings. The performance of PREMM5 in this Mexican cohort was comparable to findings reported in validation studies within other populations. Considering the spectrum of PVs identified, employing a multigene panel test is recommended for Mexican patients with CRC.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0354795","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:31:45Z","timestamp":1785864705000},"page":"e0354795","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Performance of PREMM5, clinical criteria, and immunohistochemistry for MMR proteins in genetic risk assessment of Mexican patients with colorectal cancer"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-1331","authenticated-orcid":true,"given":"Jos\u00e9 Luis","family":"Rodr\u00edguez-Olivares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dione","family":"Aguilar-y-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara N.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-6523","authenticated-orcid":true,"given":"Pamela","family":"Rivero-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Rios-Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Santuario-Facio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3765-6778","authenticated-orcid":true,"given":"Augusto","family":"Rojas-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Ortiz-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lica Leticia","family":"Barraza-Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Aranda-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazm\u00edn","family":"Arteaga-Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"De-La-Mora-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne M.","family":"Jeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Weitzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-1817","authenticated-orcid":true,"given":"Yanin","family":"Ch\u00e1varri-Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"10","key":"pone.0354795.ref001","doi-asserted-by":"crossref","first-page":"695","DOI":"10.6004\/jnccn.2024.0061","article-title":"Genetic\/familial high-risk assessment: colorectal, endometrial, and gastric, version 3.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"R Hodan","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"pone.0354795.ref002","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"pone.0354795.ref003","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamaoncol.2016.5194","article-title":"Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer","volume":"3","author":"R Pearlman","year":"2017","journal-title":"JAMA Oncol"},{"issue":"4","key":"pone.0354795.ref004","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.11.004","article-title":"Germline genetic features of young individuals with colorectal cancer","volume":"154","author":"EM Stoffel","year":"2018","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0354795.ref005","article-title":"A comprehensive framework for early-onset colorectal cancer research","volume":"23","author":"C Eng","year":"2022","journal-title":"Lancet Oncol"},{"issue":"11","key":"pone.0354795.ref006","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.30433","article-title":"Trends in the incidence of early-onset colorectal adenocarcinoma among Black and White US residents aged 40 to 49 years, 2000-2017","volume":"4","author":"EM Montminy","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"pone.0354795.ref007","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02053699","article-title":"The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)","volume":"34","author":"HF Vasen","year":"1991","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"pone.0354795.ref008","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","article-title":"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC","volume":"116","author":"HF Vasen","year":"1999","journal-title":"Gastroenterology"},{"issue":"23","key":"pone.0354795.ref009","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/jnci\/89.23.1758","article-title":"A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Bethesda Guidelines","volume":"89","author":"MA Rodriguez-Bigas","year":"1997","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"pone.0354795.ref010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"A Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"pone.0354795.ref011","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10689-012-9591-x","article-title":"EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients","volume":"12","author":"MJL Ligtenberg","year":"2013","journal-title":"Fam Cancer"},{"issue":"4","key":"pone.0354795.ref012","first-page":"397","article-title":"Mismatch repair protein expression in colorectal cancer","volume":"4","author":"EAH Kheirelseid","year":"2013","journal-title":"J Gastrointest Oncol"},{"issue":"19","key":"pone.0354795.ref013","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1200\/JCO.2016.69.6120","article-title":"Development and validation of the PREMM5 model for comprehensive risk assessment of Lynch syndrome","volume":"35","author":"F Kastrinos","year":"2017","journal-title":"J Clin Oncol"},{"key":"pone.0354795.ref014","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1200\/GO.20.00587","article-title":"Development and Pilot Implementation of the Genomic Risk Assessment for Cancer Implementation and Sustainment (GRACIAS) Intervention in Mexico","volume":"7","author":"KR Blazer","year":"2021","journal-title":"JCO Glob Oncol"},{"issue":"7","key":"pone.0354795.ref015","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.pan.2024.09.018","article-title":"Prevalence and spectrum of germline pathogenic variants in cancer susceptibility genes among mexican patients with exocrine pancreatic cancer","volume":"24","author":"JL Rodr\u00edguez-Olivares","year":"2024","journal-title":"Pancreatology"},{"key":"pone.0354795.ref016","doi-asserted-by":"crossref","first-page":"101874","DOI":"10.1016\/j.gimo.2024.101874","article-title":"Addressing the need for genetic cancer risk assessment in Mexico: From establishment of a formal program to delivery innovation and expansion","volume":"2","author":"Y Ch\u00e1varri-Guerra","year":"2024","journal-title":"Genet Med Open"},{"issue":"10","key":"pone.0354795.ref017","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-113-10-779","article-title":"Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location","volume":"113","author":"JA Bufill","year":"1990","journal-title":"Ann Intern Med"},{"issue":"5","key":"pone.0354795.ref018","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"S Richards","year":"2015","journal-title":"Genet Med"},{"issue":"3","key":"pone.0354795.ref019","article-title":"Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study","volume":"20","author":"PLS Uson","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"pone.0354795.ref020","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2016.71.0012","article-title":"Cancer susceptibility gene mutations in individuals with colorectal cancer","volume":"35","author":"MB Yurgelun","year":"2017","journal-title":"J Clin Oncol"},{"issue":"11","key":"pone.0354795.ref021","first-page":"5571","article-title":"Prevalence and spectrum of germline cancer susceptibility gene variants and somatic second hits in colorectal cancer","volume":"11","author":"H Liao","year":"2021","journal-title":"Am J Cancer Res"},{"issue":"19","key":"pone.0354795.ref022","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.3390\/ijms231911549","article-title":"A Previously Unrecognized Molecular Landscape of Lynch Syndrome in the Mexican Population","volume":"23","author":"A Padua-Bracho","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"11","key":"pone.0354795.ref023","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31855","article-title":"Lynch syndrome in Mexican-Mestizo families: Genotype, phenotypes, and challenges in cascade testing among relatives at risk","volume":"10","author":"P Rivero-Garc\u00eda","year":"2024","journal-title":"Heliyon"},{"issue":"18","key":"pone.0354795.ref024","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa043146","article-title":"Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)","volume":"352","author":"H Hampel","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"pone.0354795.ref025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1053\/j.gastro.2013.12.002","article-title":"Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors","volume":"146","author":"AR Mensenkamp","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0354795.ref026","article-title":"MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features","volume":"8","author":"X Li","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"pone.0354795.ref027","doi-asserted-by":"crossref","first-page":"743","DOI":"10.6004\/jnccn.2023.7020","article-title":"Constitutional MLH1 Methylation Is a Major Contributor to Mismatch Repair-Deficient, MLH1-Methylated Colorectal Cancer in Patients Aged 55 Years and Younger","volume":"21","author":"MP Hitchins","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"35","key":"pone.0354795.ref028","doi-asserted-by":"crossref","first-page":"5783","DOI":"10.1200\/JCO.2008.17.5950","article-title":"Feasibility of screening for Lynch syndrome among patients with colorectal cancer","volume":"26","author":"H Hampel","year":"2008","journal-title":"J Clin Oncol"},{"key":"pone.0354795.ref029","article-title":"Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome","volume":"7","author":"M Ranganathan","year":"2023","journal-title":"JCO Precis Oncol"},{"issue":"3","key":"pone.0354795.ref030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1056\/NEJMoa022289","article-title":"Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer","volume":"349","author":"CM Ribic","year":"2003","journal-title":"N Engl J Med"},{"issue":"25","key":"pone.0354795.ref031","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer","volume":"386","author":"A Cercek","year":"2022","journal-title":"N Engl J Med"},{"issue":"21","key":"pone.0354795.ref032","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2400634","article-title":"Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer","volume":"390","author":"M Chalabi","year":"2024","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0354795.ref033","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJMoa2507874","article-title":"Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer","volume":"394","author":"FA Sinicrope","year":"2026","journal-title":"N Engl J Med"},{"issue":"23","key":"pone.0354795.ref034","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer","volume":"383","author":"T Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"issue":"21","key":"pone.0354795.ref035","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa2402141","article-title":"Nivolumab plus ipilimumab in microsatellite-instability-high metastatic colorectal cancer","volume":"391","author":"T Andre","year":"2024","journal-title":"N Engl J Med"},{"key":"pone.0354795.ref036","article-title":"Nonoperative management of mismatch repair-deficient tumors","author":"A Cercek","year":"2025","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0354795.ref037","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000430097","article-title":"Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study","volume":"89","author":"M Landon","year":"2015","journal-title":"Oncology"},{"issue":"1","key":"pone.0354795.ref038","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database","volume":"22","author":"M Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"issue":"8","key":"pone.0354795.ref039","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1136\/jmedgenet-2011-100082","article-title":"Determining the frequency of de novo germline mutations in DNA mismatch repair genes","volume":"48","author":"AK Win","year":"2011","journal-title":"J Med Genet"},{"issue":"2","key":"pone.0354795.ref040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7326\/0003-4819-155-2-201107190-00002","article-title":"Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis","volume":"155","author":"U Ladabaum","year":"2011","journal-title":"Ann Intern Med"},{"issue":"5","key":"pone.0354795.ref041","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/M22-0846","article-title":"Population Genomic Screening for Three Common Hereditary Conditions: A Cost-Effectiveness Analysis","volume":"176","author":"GF Guzauskas","year":"2023","journal-title":"Ann Intern Med"},{"issue":"3","key":"pone.0354795.ref042","first-page":"65","article-title":"Risks of colorectal cancer among TP53 mutation carriers in the LIFT UP study","volume":"24","author":"S Gruber","year":"2025","journal-title":"Fam Cancer"},{"issue":"35","key":"pone.0354795.ref043","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1200\/JCO.22.00120","article-title":"Development and validation of the PREMMplus model for multigene hereditary cancer risk assessment","volume":"40","author":"MB Yurgelun","year":"2022","journal-title":"J Clin Oncol"},{"issue":"4","key":"pone.0354795.ref044","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jmoldx.2018.03.010","article-title":"Efficient Detection of Copy Number Mutations in PMS2 Exons with a Close Homolog","volume":"20","author":"DS Herman","year":"2018","journal-title":"J Mol Diagn"},{"issue":"9","key":"pone.0354795.ref045","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1158\/0008-5472.CAN-2401-2","article-title":"Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers","volume":"64","author":"A Goel","year":"2004","journal-title":"Cancer Res"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354795","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:31:55Z","timestamp":1785864715000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354795"}},"subtitle":[],"editor":[{"given":"Miquel","family":"Vall-llosera Camps","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0354795","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}